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BRIEF COMMUNICATION
CARBOHYDRATE ASSIMILATION PROFILES OF BRAZILIAN Candida dubliniensis
ISOLATES BASED ON ID 32C SYSTEM
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SUMMARY
The purpose of the present study was to evaluate the identification of 19 Brazilian C. dubliniensis based on the biochemical
profile exhibited when tested by the commercial identification kit ID 32C (bioMerieux). Thirteen of the isolates were rigorously
identified as C. dubliniensis and the remaining isolates (six) were considered as having a doubtful profile but the software also
suggested that there was 83.6% of chances for them to be C. dubliniensis. As well as pointed by the literature the identification
obtained by phenotypic tests should be considered presumptive for C. dubliniensis due to variability of this new species.
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INTRODUCTION
Candida dubliniensis is a newly described species of Candida,
which was first reported by SULLIVAN et al. in 199521. Despite C.
dubliniensis has been recovered from several body sites in many human
populations, it is most often isolated from the oral cavities of patients
infected with the Human Immunodeficiency Virus. This new yeast is
found all over the world2,4,10,15,16,18,22 and is similar to C. albicans in a
number of ways including morphology and metabolism, being
considered as an opportunistic yeast pathogen but also recognized as a
minor constituent of the normal human oral microbial flora11,15.
 A multicenter surveillance study conducted in Brazil by MILÁN
et al.10 showed a 2.8% prevalence rate of HIV-infected/AIDS adult
patients harboring C. dubliniensis in their oral cavities. In contrast
with patients from the north-hemisphere countries where this particular
species may be recovered from 27% of asymptomatic HIV-positive
patients and 32% of AIDS patients with oral candidiasis21, different
studies from South America suggest that C. dubliniensis is more rarely
found2,10,16,18.
C. dubliniensis is phylogenetically related to C. albicans and the
distinction between C. dubliniensis and C. albicans remains a challenge
for clinical microbiology laboratories. The importance of the correct
identification seems to be meaningful for epidemiological proposals
and therapeutic interventions. The majority of C. dubliniensis isolates
show susceptibility to currently used antifungal drugs12, but it has been
demonstrated that they may rapidly develop a stable resistance to
fluconazole upon in vitro exposure11.
Various phenotype screening tests have been used to discriminate
those organisms, including the colony color on CHROMagar Candida,
growth temperature test at 42/45 °C14, sugar assimilation tests and, β-
glucosidase activity17,23. In addition, C. dubliniensis strains may be
recognized by their ability to produce abundant chlamydospores often
observed in triplets or in contiguous pairs21, to coaggregate in vitro
with Fusobacterium nucleatum8, to produce rough colonies and
chlamydospores on Staib agar20 and also by its intolerance to 6.5%
sodium chloride broth3 and inability to produce an opacity halo at Tween
80 agar19. It is important to highlight that no single phenotype test has
proven to be highly effective and the use of genotypic tests may be
necessary for definitive identification purposes7,9,22. Considering that
molecular methods are relatively time consuming and expensive there
is a need for clinical laboratories to have phenotype tests as reliable as
the carbohydrate assimilation profiles.
The present study was undertaken to evaluate the biochemical
profile exhibited by nineteen Brazilian C. dubliniensis isolates formerly
identified by genotyping methods, when tested by the commercial
identification kit ID 32C (bioMerieux). This kit provides an evaluation
for the assimilation of 30 carbon sources and for the growth of yeasts
in the presence of cyclohexemide. The assays were performed according
to the manufacturer’s instructions. It consists of 32 cupules, each
containing a dehydrated carbohydrate substrate. A semi-solid,
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chemically defined, minimal medium was inoculated with a suspension
of the yeast organism to be tested. After 24-48 hours of incubation,
growth in each cupule was detected by visual reading. Identification
was obtained using the identification software (bioMerieux).
After 48 h of incubation, the ID 32 C system was able to rigorously
identify and classify great part of the isolates as positive (13) for C.
dubliniensis at three different levels: excellent (seven), very good (five)
and as good (one). Almost all the remaining isolates (six) were
considered as having a doubtful profile but the software also suggest
that there is 83.6% of chances for them to be C. dubliniensis. It should
be pointed here that in laboratory routine the percentage of 83.6%
would be an important indication of the species and should be taken
into account.
Some assimilation profiles were not consistent among the strains
of C. dubliniensis tested once they exhibited variation of results among
different isolates tested. The lower agreement rate was found with
results generated by palatinose, 2-keto-gluconate, N-acetylglucosamine,
lactate, trehalose, galactose and sorbitol (Table 1). Best discrimination
and consistence of results were obtained with α-methyl-D-glucoside
(MDG) and xylose (XYL) that were not assimilated by 100% of the
isolates tested. Lactate (LAT) and trehalose (TRE) were assimilated
by one isolate. Our results were slightly different from those reported
by PINCUS et al.13 in which 30% of the isolates assimilated trehalose
(TRE) and no one of the isolates assimilated lactate (LAT). When
SULLIVAN et al.21 described C. dubliniensis as a new species, they
reported that this organism was not able to assimilate xylose (XYL)
and α-methyl-D-glucoside (MDG). However, some positive reactions
with this subtract were described previously by testing some strains of
C. dubliniensis with commercial kits as the Vitek system5,13.
The results obtained in the present study are in accordance with
the results reported by other authors6,13. The major identification
problem related to the ID32 system was the discrepancy of results
generated by some reactions causing misidentification of C.
dubliniensis. It has been reported that variations in the density of the
inoculum may produce false-positive or false-negative results requiring
the adjustment of the inoculum to the proper density5. Otherwise, one
could speculate that different strains of C. dubliniensis may exhibit
some differences in their metabolic pathways like that involving
trehalose and N-acetylglucosamine24. The variant phenotypes could
also arise from the process of high-frequency switching to adapt to the
host environment, like almost observed with C. albicans1.
In conclusion, despite the promising results obtained with the ID
32C system, this method exhibited some limitations in the identification
of C. dubliniensis. Since variability has been reported in the literature,
the results obtained by phenotypic tests should be considered presumptive
for C. dubliniensis and one or more confirmatory tests should be
employed. Therefore, we do not recommend the use of ID 32C system
as the only screening test for the identification of C. dubliniensis.
RESUMO
Identificação de Candida dubliniensis isoladas no Brasil, através
do método comercial ID 32C
Dezenove culturas de C. dubliniensis isoladas no Brasil, previamente
identificadas através de métodos genotípicos, foram avaliadas pelo kit
comercial ID 32C (bioMerieux). Treze culturas foram identificadas como
C. dubliniensis, mas as demais (seis) evidenciaram perfil duvidoso,
embora o software do sistema sugerisse 83,6% de chances das mesmas
pertencerem à espécie C. dubliniensis. A literatura tem registrado grande
variabilidade fenotípica com esta espécie e, por isto, as identificações
obtidas com este sistema deverão ser consideradas como presuntivas.
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